Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 Study Group

Nom du journal : J Clin Oncol

Année : 2005

Volume : 23

Page de départ : 4265

Page de fin : 4274

Auteurs: Marty M, Cognetti F, Maraninchi D, Snyder R, Mauriac L, Tubiana-Hulin M, Chan S, Grimes D, Antón A, Lluch A, Kennedy J, O'Byrne K, Conte PF, Green M, Ward C, Mayne K, Extra JM, Extra JM,